Caitlin M. Padgett, Melissa M. Bollmeyer, Kaleb Boswinkle, Anthony T. Iavarone, Valérie de Crécy-Lagard, R. David Britt, Wen Zhu
{"title":"Characterization of a Heme-Binding Radical SAM Enzyme HemW from Moraxella catarrhalis","authors":"Caitlin M. Padgett, Melissa M. Bollmeyer, Kaleb Boswinkle, Anthony T. Iavarone, Valérie de Crécy-Lagard, R. David Britt, Wen Zhu","doi":"10.1021/acsbiomedchemau.6c00111","DOIUrl":null,"url":null,"abstract":"<p><em>Moraxella catarrhalis</em> is\r\nan emerging\r\nhuman respiratory pathogen responsible for various infectious diseases.\r\nRecent transposon sequencing analysis identified <em>yggW</em> (renamed <em>hemW</em>) as essential for <em>M. catarrhalis</em> growth under iron-limiting conditions,\r\nmimicking host-imposed nutritional immunity. HemW is annotated as\r\na putative radical <em>S</em>-adenosylmethionine (SAM) enzyme\r\nand belongs to the HemN-like subfamily, but its biochemical properties\r\nremain unclear. Here, we report on the first experimental characterization\r\nof <em>M. catarrhalis</em> HemW (<em>Mc</em>HemW). Our bioinformatic analysis confirmed its evolutionary relationship\r\nwith the putative heme-binding radical SAM enzyme HemW in <em>Escherichia coli</em>. We experimentally demonstrated\r\nthat <em>Mc</em>HemW contains a catalytically active [4Fe-4S]\r\ncluster and binds heme through biochemical assays and spectroscopy.\r\nUsing hydrogen–deuterium exchange mass spectrometry, we demonstrated,\r\nfor the first time, that the heme-binding site resides within the\r\nC-terminal auxiliary domain unique to HemW. These findings provide\r\nmechanistic insight into the molecular basis of heme recognition in <em>Mc</em>HemW and establish a foundation for understanding its\r\nrole in the pathogenicity of <em>M. catarrhalis</em> under iron-limited conditions.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"6 4","pages":"468–483"},"PeriodicalIF":3.5000,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.6c00111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Moraxella catarrhalis is
an emerging
human respiratory pathogen responsible for various infectious diseases.
Recent transposon sequencing analysis identified yggW (renamed hemW) as essential for M. catarrhalis growth under iron-limiting conditions,
mimicking host-imposed nutritional immunity. HemW is annotated as
a putative radical S-adenosylmethionine (SAM) enzyme
and belongs to the HemN-like subfamily, but its biochemical properties
remain unclear. Here, we report on the first experimental characterization
of M. catarrhalis HemW (McHemW). Our bioinformatic analysis confirmed its evolutionary relationship
with the putative heme-binding radical SAM enzyme HemW in Escherichia coli. We experimentally demonstrated
that McHemW contains a catalytically active [4Fe-4S]
cluster and binds heme through biochemical assays and spectroscopy.
Using hydrogen–deuterium exchange mass spectrometry, we demonstrated,
for the first time, that the heme-binding site resides within the
C-terminal auxiliary domain unique to HemW. These findings provide
mechanistic insight into the molecular basis of heme recognition in McHemW and establish a foundation for understanding its
role in the pathogenicity of M. catarrhalis under iron-limited conditions.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.